Premium
Spruce Biosciences Inc (SPRB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | Institution | 121 356 | 4,41% | US$ 6,33M | 2026-04-30 |
| Ikarian Healthcare Master Fund, L.P. | Institution | 121 356 | 4,41% | US$ 6,33M | 2026-04-30 |
| Millennium Management LLC | Institution | 111 888 | 4,07% | US$ 5,83M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 103 026 | 3,74% | US$ 5,37M | 2026-03-24 |
| Citadel Advisors LLC | Institution | 70 065 | 2,55% | US$ 3,65M | 2026-03-31 |
| Squadron Master Fund LP | Institution | 70 000 | 2,54% | US$ 3,65M | 2026-03-24 |
| Peter Boone | Initiés | 68 184 | 2,48% | US$ 3,56M | 2025-11-21 |
| ADAR1 Capital Management, LLC | Institution | 58 600 | 2,13% | US$ 3,06M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 51 671 | 1,88% | US$ 2,69M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 48 796 | 1,77% | US$ 2,54M | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 42 080 | 1,53% | US$ 2,19M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 40 000 | 1,45% | US$ 2,09M | 2026-03-31 |
| Abingworth LLP | Institution | 38 620 | 1,40% | US$ 2,01M | 2026-03-31 |
| Abingworth Bioventures VII LP | Institution | 38 620 | 1,40% | US$ 2,01M | 2026-02-18 |
| Armistice Capital Master Fund Ltd. | Institution | 28 923 | 1,05% | US$ 1,51M | 2025-04-01 |
| Armistice Capital LLC | Institution | 28 923 | 1,05% | US$ 1,51M | 2025-04-01 |
| Odlander, Fredrikson & Co. AB | Institution | 27 201 | 0,99% | US$ 1,42M | 2025-10-07 |
| HealthCap VIII, L.P. | Institution | 27 201 | 0,99% | US$ 1,42M | 2025-10-07 |
| Quinn Opportunity Partners LLC | Institution | 26 810 | 0,97% | US$ 1,40M | 2026-03-31 |
| Exoduspoint Partners Master Fund, LP | Institution | 22 000 | 0,80% | US$ 1,15M | 2026-04-27 |
| ExodusPoint Capital Management, LP | Institution | 22 000 | 0,80% | US$ 1,15M | 2026-04-27 |
| Dr. Javier Szwarcberg | Initiés | 19 004 | 0,69% | US$ 990,87k | 2026-03-24 |
| Vanguard Capital Management, LLC | Institution | 18 337 | 0,67% | US$ 956,09k | 2026-03-31 |
| BlackRock, Inc. | Institution | 16 938 | 0,62% | US$ 883,15k | 2026-03-31 |
| RiverVest Venture Management LLC | Institution | 15 580 | 0,57% | US$ 812,34k | 2025-01-07 |
| Geode Capital Management, LLC | Institution | 12 889 | 0,47% | US$ 672,03k | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 12 200 | 0,44% | US$ 636,11k | 2026-03-31 |
| Diadema Partners LP | Institution | 10 000 | 0,36% | US$ 521,40k | 2026-03-31 |
| RiverVest Venture Fund III LP | Institution | 8 543 | 0,31% | US$ 445,43k | 2025-01-07 |
| Mr. Samir Gharib | Initiés | 8 263 | 0,30% | US$ 430,83k | 2026-03-24 |
| Rivervest Venture Fund IV, L.P. | Institution | 7 038 | 0,26% | US$ 366,96k | 2025-01-07 |
| StemPoint Capital LP | Institution | 6 360 | 0,23% | US$ 331,61k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 5 514 | 0,20% | US$ 287,50k | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 5 506 | 0,20% | US$ 287,08k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 5 400 | 0,20% | US$ 281,56k | 2026-03-31 |
| Resolute Capital Asset Partners LLC | Institution | 4 000 | 0,15% | US$ 208,56k | 2026-03-31 |
| UBS Asset Management AG | Institution | 3 919 | 0,14% | US$ 204,34k | 2026-03-31 |
| Persistent Asset Partners Limited | Institution | 2 528 | 0,09% | US$ 131,81k | 2026-03-31 |
| Dr. Ralph Charlton | Initiés | 2 151 | 0,08% | US$ 112,15k | 2025-04-01 |
| Morgan Stanley | Institution | 1 415 | 0,05% | US$ 73,78k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
